Roby, A. Et Al. 2007. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles. CANCER BIOLOGY & THERAPY , vol.6, no.7 , 1136-1142.

Roby, A., Erdogan, S., & Torchilin, V. P. , (2007). Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles. CANCER BIOLOGY & THERAPY , vol.6, no.7, 1136-1142.

Roby, SUNA, Stma Erdogan, And Vladimir P. Torchilin. "Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles," CANCER BIOLOGY & THERAPY , vol.6, no.7, 1136-1142, 2007

Roby, SUNA Et Al. "Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles." CANCER BIOLOGY & THERAPY , vol.6, no.7, pp.1136-1142, 2007

Roby, A. Erdogan, S. And Torchilin, V. P. (2007) . "Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles." CANCER BIOLOGY & THERAPY , vol.6, no.7, pp.1136-1142.

@article{article, author={SUNA ERDOĞAN Et Al. }, title={Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles}, journal={CANCER BIOLOGY & THERAPY}, year=2007, pages={1136-1142} }